Not surprisingly, the P53 domain on TP53 gene, the most commonly mutated protein domain across 34.3% of all tumors (3358 tumors of 31 different types in the pan-cancer cohort), was determined to have a large deleterious effect on the cancer death risk, adjusting for other somatic mutation events across the genome. This evidence concerns the gene TP53 and cancer.